Autoantibodies to GP2, the major zymogen granule membrane glycoprotein, are new markers in Crohn's disease.

@article{Roggenbuck2011AutoantibodiesTG,
  title={Autoantibodies to GP2, the major zymogen granule membrane glycoprotein, are new markers in Crohn's disease.},
  author={D. Roggenbuck and D. Reinhold and T. Wex and A. Goihl and U. von Arnim and P. Malfertheiner and T. Buettner and T. Porstmann and Silvia Porstmann and B. Liedvogel and D. Bogdanos and M. Laass and K. Conrad},
  journal={Clinica chimica acta; international journal of clinical chemistry},
  year={2011},
  volume={412 9-10},
  pages={
          718-24
        }
}
  • D. Roggenbuck, D. Reinhold, +10 authors K. Conrad
  • Published 2011
  • Chemistry, Medicine
  • Clinica chimica acta; international journal of clinical chemistry
    • BACKGROUND Crohn's disease (CD) is an inflammatory bowel disease (IBD) characterized by reactivity against microbial and self antigens. Zymogen granule glycoprotein 2 (GP2) was identified as the major autoantigen of CD-specific pancreatic autoantibodies (PAB). METHODS Human GP2 was expressed in the Spodoptera frugiperda 9 (Sf9) cell line using the baculovirus system, purified by Ni-chelate chromatography, and used as antigen for anti-GP2 IgA and IgG assessment by enzyme-linked immunosorbent… CONTINUE READING
    View on PubMed
    doi.org
    63 Citations
    Highly Influencial Citations
    4
    Background Citations
    18
    Methods Citations
    11
    Results Citations
    4
    63 Citations
    Citation Type

    Citation Type

    Pancreatic GP2-specific autoantibodies are markers of crohn's disease
    • 4
    • PDF
    Chapter 51 – Antipancreatic Autoantibodies
    Pancreatic-specific autoantibodies to glycoprotein 2 mirror disease location and behaviour in younger patients with Crohn’s disease
    • 49
    Authors' response: antibodies to GP2, the major zymogen granule membrane glycoprotein, are specific for Crohn's disease and may reflect treatment response
    • 13
    Diagnostic Potential of Zymogen Granule Glycoprotein 2 Antibodies as Serologic Biomarkers in Chinese Patients With Crohn Disease
    • 8
    Ileal Inflammation May Trigger the Development of GP2-Specific Pancreatic Autoantibodies in Patients with Crohn's Disease
    • 43
    Autoantibodies against exocrine pancreas in Crohn's disease are directed against two antigens: the glycoproteins CUZD1 and GP2.
    • 57
    • PDF
    Glycoprotein 2 antibodies in Crohn's disease.
    • 38
    Loss and Gain of Tolerance to Pancreatic Glycoprotein 2 in Celiac Disease
    • 8
    • PDF
    Evidence of Crohn’s disease-related anti-glycoprotein 2 antibodies in patients with celiac disease
    • 10
    • PDF

    References

    SHOWING 1-10 OF 38 REFERENCES
    Antibodies to GP2, the major zymogen granule membrane glycoprotein, in inflammatory bowel diseases
    • 47
    • Highly Influential
    Identification of GP2, the major zymogen granule membrane glycoprotein, as the autoantigen of pancreatic antibodies in Crohn’s disease
    • 128
    Autoimmunity to pancreatic juice in Crohn's disease. Results of an autoantibody screening in patients with chronic inflammatory bowel disease.
    • 133
    Autoantibodies to asialoglycoprotein receptor (ASGPR) measured by a novel ELISA--revival of a disease-activity marker in autoimmune hepatitis.
    • 34
    Serological differentiation of inflammatory bowel diseases
    • 45
    The prevalence and diagnostic value of perinuclear antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibodies in patients with inflammatory bowel disease in mainland China.
    • F. Zhou, B. Xia, +6 authors J. Li
    • Medicine
    • Clinica chimica acta; international journal of clinical chemistry
    • 2010
    • 18
    Pancreatic Autoantibodies Are Associated with Reactivity to Microbial Antibodies, Penetrating Disease Behavior, Perianal Disease, and Extraintestinal Manifestations, But Not with NOD2/CARD15 or TLR4 Genotype in a Hungarian IBD Cohort
    • 58
    New serological markers in inflammatory bowel disease are associated with complicated disease behaviour
    • 247
    Antibodies to a trypsin sensitive pancreatic antigen in chronic inflammatory bowel disease: specific markers for a subgroup of patients with Crohn's disease.
    • 93
    • PDF
    Advances in clinical laboratory tests for inflammatory bowel disease.
    • 49